Answer
Headache and infusion-site reactions were very common (≥1/10) in clinical studies of Subgam (human normal immunoglobulin).
Sources for this answer
- Subgam, Human normal immunoglobulin solutionBio Products Laboratory Limited · emc · SmPC §4.8 Undesirable effects · Version 12Document updated
Sources checked